Healthcare News and Research

Latest Healthcare News and Research

Researchers develop web-based approach to solve personal health assessment problem

Health literacy is a prerequisite for well being in the developed world with five out of five ailments being treatable by patients themselves given access to appropriate information.

11 Mar 2011

FDA approves Matrix NDA for Zidovudine Tablets

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration under the President's Emergency Plan for AIDS Relief for its New Drug Application for Zidovudine Tablets, 100 mg.

10 Mar 2011

TGen launches globalCure initiative to fight against pancreatic cancer

In an effort to improve treatment and one day find a cure for pancreatic cancer, the TGen Foundation today joined with key donors and community leaders to announce the creation of globalCure.

10 Mar 2011

FDA approves Covidien's LEU-based Mo-99 medical isotope

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration has approved the use of molybdenum-99 derived from low-enriched uranium (LEU) in the production of technetium-99m generators.

10 Mar 2011

Future Medicine launches Neuropsychiatry

Future Medicine Ltd has today announced the launch of Neuropsychiatry – a new bimonthly title addressing all the latest trends in the field, from R&D through to clinical application and management, presenting research, findings, analysis and commentaries from experts around the world. Neuropsychiatry is published by Future Medicine Ltd (UK, London) renowned for its collection of journals providing healthcare practitioners and research professionals with a unique source of objective, cutting-edge information on exciting trends emerging in light of advances in medicine, healthcare and clinical practice.

10 Mar 2011

Northstar fourth quarter net patient service revenue decreases to $2.2 million

Northstar Healthcare Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010.

10 Mar 2011

Matrix, dbMotion partner to market and deploy healthcare solutions in the UK

dbMotion, an innovative provider of connected healthcare solutions, and Matrix Knowledge Group, a leader in information management services, announced a partnership today to jointly market and deploy solutions throughout the United Kingdom.

10 Mar 2011

George Hoag Family Foundation awards grant to Cedars-Sinai's COACH for Kids program

Thanks to a grant from the George Hoag Family Foundation, Cedars-Sinai Medical Center's COACH for Kids and Their Families- program will be able to expand healthcare services to more homeless children living in transitional shelters in Greater Los Angeles.

10 Mar 2011

Dem leaders acknowledge Senate support for Berwick falls short

But the Centers for Medicare and Medicaid Services chief says he remains entirely focused on the job at hand.

10 Mar 2011

AHF unveils new national advertising campaign about AIDS drugs

AIDS Healthcare Foundation today unveiled a new national advertising campaign headlined, "There Is No Magic Pill," an advocacy and awareness campaign to educate and prompt discussion among gay men and others regarding Gilead Sciences and its likely plans to seek Food and Drug Administration approval for use of its blockbuster AIDS drug Truvada as a form a 'pre-exposure prophylaxis' to prevent HIV transmission.

10 Mar 2011

U-M participates in national trial for alternative approach to open heart surgery for severe aortic stenosis

The University of Michigan Cardiovascular Center, a leader in heart valve replacement, will participate in a national clinical trial to offer patients a less invasive approach to replacing diseased aortic valves.

10 Mar 2011

California leaders completes much-anticipated State Plan for Alzheimer's disease

Anticipating a catastrophic increase in Alzheimer's disease and related dementias, California leaders have completed the much-anticipated California State Plan for Alzheimer's disease, a disease estimated to double among Californians by the year 2030.

10 Mar 2011

White House appeals Florida ruling overturning health law

The administration acted quickly in order to prevent a part of the judge's recent "clarification" that would have shut down implementation of the law for now. Meanwhile, in another health law challenge, Mass. Attorney General Martha Coakley and a number of hospital associations filed separate amicus briefs in support of the federal government.

10 Mar 2011

NextGen Group subsidiary completes commercial reorganization

NextGen Group plc is pleased to announce that its subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has completed a commercial reorganization. The restructuring, which is accompanied by new management appointments, is expected to help the company execute its strategy of becoming a leading player in the growing oncology and central nervous system (CNS) biomarker markets.

10 Mar 2011

Health Dialog unveils new Shared Decision Making program for insomnia patients

Health Dialog unveiled today a new Shared Decision Making program titled "Sleeping Better: Help for Long-Term Insomnia," to give patients information they need to make informed treatment decisions for this condition.

10 Mar 2011

Feds gives Maine a break from insurance premium rules

Maine was granted leeway — the first such waiver given by the federal government — with the health law provision known as the medical-loss ratio because of concerns it would destabilize the state's insurance market.

10 Mar 2011

Medicaid and the health overhaul's goals

Media outlets report on how the health overhaul interacts with Medicaid and whether it will ultimately have a positive or negative impact on states.

9 Mar 2011

EDT receives European approval for XEPLION injection to treat schizophrenia

Elan Drug Technologies, the drug delivery unit of Elan Corporation, plc, today announced that the first injectable product using EDT's NanoCrystal technology has been approved by the European Commission.

9 Mar 2011

U.S. FDA approves Hospira's docetaxel to treat variety of cancers

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced U.S. Food and Drug Administration approval of docetaxel. The medication is a generic version of Sanofi-Aventis's Taxotere, and Hospira expects to launch the product later this month.

9 Mar 2011

Roundup: Legislatures pressured on health cuts, malpractice laws; Mass. Blue Cross board salaries; pension costs

This week, the Assembly and Senate will debate the final package of budget reductions. Among the $6 billion in health-related cuts is the elimination of the Maddy Fund, a $55 million attempt to reimburse emergency departments for indigent care.

9 Mar 2011